Trials / Completed
CompletedNCT03737422
The Effects of Hesperidin and Flaxseed in Prediabetes
Evaluation of the Effects of Hesperidin and Flaxseed Supplementation in Patients With Prediabetes
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- National Nutrition and Food Technology Institute · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
To study the effects of Hesperidin and flaxseed supplement in patients with prediabetes, 50 patients will be randomly allocated to control group or 2 capsules Hesperidin and 30 gram flaxseed for 12 weeks; both groups will be advised to adherence the investigators' diet and exercise program too. At the first and the end of the intervention, lipid profiles, blood pressure, blood sugar, inflammatory and anthropometric factors will be assessed and compared between groups.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | hesperidin and flaxseed | 2 capsuls hesperidin and 30 g flaxseed |
| OTHER | control | no supplementation |
Timeline
- Start date
- 2018-01-01
- Primary completion
- 2018-10-01
- Completion
- 2018-12-01
- First posted
- 2018-11-09
- Last updated
- 2019-07-26
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT03737422. Inclusion in this directory is not an endorsement.